-
1دورية أكاديمية
المؤلفون: Petrella, Teresa M., Robert, Caroline, Richtig, Erika, Miller, Wilson H., Masucci, Giuseppe V., Walpole, Euan, Lebbe, Celeste, Steven, Neil, Middleton, Mark R., Hille, Darcy, Zhou, Wei, Ibrahim, Nageatte, Cebon, Jonathan
مصطلحات موضوعية: Advanced melanoma, EORTC QLQ-C30, Health-related quality of life, KEYNOTE-006, Patient-reported outcomes, Pembrolizumab, 1306 Cancer Research, 2730 Oncology
العلاقة: orcid:0000-0001-6105-9039
-
2دورية أكاديمية
المؤلفون: Robert, Caroline1 (AUTHOR) caroline.robert@gustaveroussy.fr, Ribas, Antoni2 (AUTHOR), Schachter, Jacob3 (AUTHOR), Arance, Ana4 (AUTHOR), Grob, Jean-Jacques5 (AUTHOR), Mortier, Laurent6 (AUTHOR), Daud, Adil7 (AUTHOR), Carlino, Matteo S8 (AUTHOR), McNeil, Catriona M9 (AUTHOR), Lotem, Michal10 (AUTHOR), Larkin, James M G11 (AUTHOR), Lorigan, Paul12 (AUTHOR), Neyns, Bart13 (AUTHOR), Blank, Christian U14 (AUTHOR), Petrella, Teresa M15 (AUTHOR), Hamid, Omid16 (AUTHOR), Su, Shu-Chih17 (AUTHOR), Krepler, Clemens17 (AUTHOR), Ibrahim, Nageatte17 (AUTHOR), Long, Georgina V18 (AUTHOR)
المصدر: Lancet Oncology. Sep2019, Vol. 20 Issue 9, p1239-1251. 13p.
مصطلحات موضوعية: *MELANOMA, *PEMBROLIZUMAB, *PROGRESSION-free survival
الشركة/الكيان: MERCK & Co. Inc. 001317064 MRK
-
3دورية أكاديمية
المؤلفون: Schachter, Jacob1 jacob.schachter@sheba.health.gov.il, Ribas, Antoni2, Long, Georgina V.3, Arance, Ana4, Grob, Jean-Jaques5, Mortier, Laurent6, Daud, Adil7, Carlino, Matteo S.8, McNeil, Catriona9, Lotem, Michal10, Larkin, James11, Lorigan, Paul12, Neyns, Bart13, Blank, Christian14, Petrella, Teresa M.15, Hamid, Omid16, Honghong Zhou17, Ebbingbaus, Scot18, Ibrahim, Nageatte18, Robert, Caroline19
المصدر: Lancet. 10/21/2017, Vol. 390 Issue 10105, p1853-1862. 10p. 1 Diagram, 3 Charts, 2 Graphs.
مصطلحات موضوعية: *PEMBROLIZUMAB, *IPILIMUMAB, *MELANOMA treatment, *RANDOMIZED controlled trials, *SURVIVAL analysis (Biometry), *THERAPEUTICS